CIK: 1733272 - Address: C/O Bioxcel Therapeutics, Inc., 555 Long Wharf Drive, 12Th Floor, New Haven, CT 06511
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/17/24 18:03
12/16/24
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS.d00.353100-129D
10/3/24 21:54
10/3/24
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS-40.55000-7-2028D
9/17/24 19:23
9/16/24
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS.d00.689300-214D
6/18/24 21:27
6/17/24
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS.d01.2800-313D
4/8/24 19:30
4/4/24
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS.d-32.640-1-813D
3/16/23 18:01
3/15/23
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS.d-1919.690-1-99D
1/24/23 20:08
1/20/23
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS-1,50030.000-50-868D
3/17/21 17:00
3/15/21
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS-72848.500-15-2058D
2/18/21 16:56
2/16/21
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS-86557.680-15-1773D
1/27/21 16:25
1/25/21
BTAIBioxcel Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsYocca FrankCTOChief ScS.d-72648.390-15-1588D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact